DATADOSE, LLC

An intelligent dosing platform incorporating comprehensive governance and regulatory compliance capabilities for injectable medication administration. The platform includes regulatory tracking modules configured to monitor compliance with Merit-based Incentive Payment System (MIPS) requirements, STAR quality metrics for Medicare and Medicaid programs, and federal fraud, waste, and abuse (FWA) program standards. The system features audit trail generation modules that create tamper-proof documentation with cryptographic signatures and immutable timestamping for regulatory reporting and compliance validation activities. Compliance assessment modules evaluate medication administration events against regulatory benchmarks and quality performance indicators, while automated reporting systems generate submissions for oversight bodies and fraud prevention agencies. The platform incorporates fraud detection capabilities, compliance dashboard visualization, risk assessment modules, and real-time alert systems to ensure comprehensive regulatory compliance and audit trail management across healthcare networks and injectable medication administration environments.

A device may establish communication between the plurality of intelligent injection devices and an artificial intelligence-powered clinical research platform configured to manage a clinical trial or research program. A device may analyze, via the artificial intelligence platform, clinical trial protocol requirements including study design parameters, randomization schemes, blinding protocols, and adverse event monitoring requirements to generate coordinated medication administration strategies across the plurality of intelligent injection devices. A device may apply research protocol constraints to restrict medication selection, dosage calculations, administration timing, and patient assignment across the plurality of intelligent injection devices. A device may generate real-time coordination instructions through the artificial intelligence platform including synchronized administration timing across multiple sites, dosage verification protocols for different treatment arms, and compliance monitoring procedures tailored to specific research protocol requirements.

A device may receive patient-specified supplement regimen data through the supplement regimen compliance platform. A device may validate a proposed supplement administration against the patient-specified supplement regimen stored in the supplement regimen compliance platform. A device may constrain intelligent injection device operation through the microprocessor to permit supplement administration only upon successful validation of conformance with the patient-specified supplement regimen. A device may administer a plurality of supplement types simultaneously through the intelligent injection device, wherein the simultaneous injection includes delivering multiple nutraceuticals, vitamins, or health supplements in predetermined ratios that conform to the patient-specified supplement regimen. A device may unlock the switch of the intelligent injection device during authorized supplement administration. A device may automatically transmit, via the wireless module, administration data from the intelligent injection device to the supplement regimen compliance platform in response to triggering the switch.

A device may establish communication between the intelligent injection device and a veterinary artificial intelligence platform configured with species-specific treatment protocols and veterinary medical standard enforcement capabilities. A device may analyze, via the veterinary artificial intelligence platform, animal patient characteristics. A device may apply at least one veterinary medical standard constraint to restrict medication selection, dosage calculations, and administration techniques to only those conforming to an approved veterinary therapeutic guideline for the identified animal species. A device may generate real-time veterinary guidance through the artificial intelligence platform including injection site selection optimized for animal anatomy, needle insertion depth appropriate for species-specific tissue characteristics, and administration timing coordinated with veterinary treatment schedules. A device may monitor administration progress through sensor data from the intelligent injection device and providing species-specific corrective feedback through real-time analysis of injection parameters.

A device may establish communication between the intelligent injection device and an electronic patient portal. A device may unlock a switch of the intelligent injection device during medication administration. A device may automatically transmit, via the wireless module, medication administration data from the intelligent injection device to the electronic patient portal in response to medication administration. A device may analyze the medication administration data to determine a patient medication profile. A device may generate targeted sponsored content based on the patient medication profile. A device may present the targeted sponsored content through the electronic patient portal interface to the patient and healthcare personnel. A device may record sponsored content engagement data including content viewing duration, interaction events, and response metrics in the electronic patient portal for sponsored content optimization.

A device may establish communication between the intelligent injection device and a telemedicine platform configured to facilitate healthcare personnel interaction with patients. A device may receive, via the telemedicine platform, healthcare personnel instructions for medication administration to a patient. A device may unlock the intelligent injection device to permit medication administration. A device may automatically transmit, via a wireless module, medication administration data from the intelligent injection device to the telemedicine platform in response to a confirmed dose administration using the intelligent injection device. A device may record the medication administration data in an electronic patient portal comprising a medical chart accessible by both healthcare personnel and the patient.

An intelligent virtual care assistant system for injectable medication administration provides real-time monitoring and management of adherence to injectable administration plans. The system includes real-time monitoring systems that track injection timing, dosage compliance, patient biometric data, or administration completion status, intelligent virtual care assistant modules that perform tasks based on user commands and healthcare provider plans while delivering alerts related to health metrics, biometrics, medications, or injection schedules, or adherence management modules that analyze compliance patterns and generate personalized recommendations. The system features user interface modules displaying injection schedules and compliance metrics through smart glasses and other display devices, alert generation systems for scheduled injections and missed doses, data integration modules processing information from multiple sources, artificial intelligence modules that learn user patterns, or scheduling coordination modules managing injection timing. This integrated approach enhances patient engagement, improves medication adherence, or optimizes treatment outcomes through intelligent automation and personalized care assistance.

An AI patient guidance system for injectable medication administration combines intelligent injection devices with artificial intelligence guidance modules to provide real-time instructions for proper injection technique. The system includes intelligent injection devices that administer medication and collect administration data including injection completion status, dosage volume, administration timing, or patient biometric data, or AI guidance modules that provide real-time instructions, guide patients through injection site selection, needle insertion angle, injection depth, or administration timing while adapting guidance based on patient skill level and medication type. The system features machine learning modules for analyzing patient characteristics and historical patterns, patient interface modules delivering guidance through visual displays, audio instructions, haptic feedback, or augmented reality overlays, dosage verification modules, compliance scoring capabilities, adaptive learning algorithms, or confirmation systems. This comprehensive approach improves injection technique accuracy, enhances patient compliance, or ensures proper medication administration through personalized, intelligent guidance.

A mesh network medication coordination system enables communication between intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices to prevent adverse drug interactions in hospital settings. The system includes mesh network infrastructure supporting multiple networked devices, dosage measurement devices that directly measure or infer dosage administration including injection completion detection, medication volume measurement, administration timing data, or patient biometric responses, or a coordination module that coordinates medication administration timing across multiple devices. The system features drug interaction analysis capabilities, real-time monitoring of patient vital signs and medication effectiveness, alert generation for potential interactions and dosing conflicts, or data synchronization across all networked devices. This integrated approach optimizes dosing intervals, prevents conflicting medication schedules, synchronizes administration events, or maintains consistent medication administration data across the mesh network to enhance patient safety and treatment efficacy.

An immutable chain of custody system for injectable medications utilizes blockchain technology to create tamper-proof records of medication transfers from manufacturers through distributors, delivery contractors, or healthcare providers to patient administration. The system includes a custody tracking module that generates immutable blockchain records, a device integration module that receives custody data from intelligent injection devices including geolocation, temperature monitoring, biometric verification, environmental condition, or administration event data, or a smart contract execution module that automatically updates blockchain records upon custody transfer events. The system features multi-party authentication for supply chain participants, sensor data collection throughout the custody chain, verification modules for tracking location and environmental conditions, immutable audit trails, or automated alert systems for custody violations. This comprehensive approach ensures medication integrity, regulatory compliance, or fraud prevention throughout the pharmaceutical supply chain while maintaining complete transparency and accountability.